Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
1990-3-8
|
pubmed:abstractText |
Tumours from 117 patients with breast cancer operated during a 5-month period 1975-1976 were investigated by absorbance scanning cytophotometry. The relations of these data to breast cancer recurrence and death during a follow-up period of 8.5 years were analysed using Cox's proportional hazards model. When individually tested, nodal status, grade of malignancy and high rates of proliferation, as indicated by cells in S-phase, were statistically significant predictors of the clinical outcome. The risk ratio associated with S-phase decreased significantly over time from primary treatment. No significant relation was found between DNA-ploidy or tumour size and the clinical course. In the multivariate analysis, based on 76 patients, nodal status alone was a significant prognostic factor.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0284-186X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
28
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
801-6
|
pubmed:dateRevised |
2009-5-12
|
pubmed:meshHeading |
pubmed-meshheading:2611033-Adult,
pubmed-meshheading:2611033-Aged,
pubmed-meshheading:2611033-Aged, 80 and over,
pubmed-meshheading:2611033-Breast Neoplasms,
pubmed-meshheading:2611033-Cytophotometry,
pubmed-meshheading:2611033-DNA, Neoplasm,
pubmed-meshheading:2611033-Female,
pubmed-meshheading:2611033-Humans,
pubmed-meshheading:2611033-Lymphatic Metastasis,
pubmed-meshheading:2611033-Middle Aged,
pubmed-meshheading:2611033-Neoplasm Metastasis,
pubmed-meshheading:2611033-Neoplasm Staging,
pubmed-meshheading:2611033-Ploidies,
pubmed-meshheading:2611033-Prognosis
|
pubmed:year |
1989
|
pubmed:articleTitle |
Cytophotometric estimation of cell proliferation in breast cancer. Correlation to the clinical course during long-term follow-up.
|
pubmed:affiliation |
Department of Oncology, University Hospital, Linköping, Sweden.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|